Getting a denial letter from your insurance company when you're managing a chronic disease can feel like a door slamming shut. But a denial isn't necessarily the final word — it's often the beginning of a process. Understanding how appeals work, what strengthens them, and where the leverage points are can make a real difference in the outcome.
Before building an appeal, it helps to understand why the denial happened. The reason matters — because the right response depends entirely on the specific grounds stated in that letter.
Common denial reasons include:
Your denial letter must legally explain the specific reason. If it doesn't, that's worth noting — requesting clarification is a reasonable first step.
This is the first-level appeal, filed directly with your insurance company. You're asking the same insurer to review its own decision. While that may sound circular, internal appeals do succeed — particularly when new clinical documentation is submitted or when the original denial involved an administrative error.
If an internal appeal is denied, you typically have the right to request an external independent review. An organization unaffiliated with your insurer evaluates the case. Under federal law (and most state laws), insurers must comply with external reviewer decisions on clinical denials.
External reviews tend to carry more weight for medical necessity and experimental treatment disputes because the reviewer is a neutral clinical expert, not a company employee.
The quality of your documentation is usually the deciding factor. A thin appeal is easy to deny. A well-documented one creates real pressure for reconsideration.
Request a copy of your insurer's coverage determination criteria for the treatment in question. Appeals that directly address the insurer's stated criteria — and show the treatment meets them — are more persuasive than generic submissions.
Published clinical studies or treatment guidelines that support medical necessity can strengthen your case, particularly if the denial cites lack of evidence or classifies the treatment as experimental.
| Stage | Typical Timeframe | Notes |
|---|---|---|
| File internal appeal | Usually 180 days from denial date | Verify your plan's specific deadline |
| Insurer reviews internal appeal | Varies by urgency; expedited reviews for urgent cases | Federal law sets outer limits for regulated plans |
| File external review | Typically after internal appeal is exhausted | Some states allow concurrent filing |
| External review decision | Generally faster than internal process | Decision is typically binding |
⚠️ Deadlines matter significantly. Missing an appeal window can forfeit your rights to that level of review. Confirm the specific deadlines in your denial letter and plan documents.
No two appeals are identical, and outcomes vary based on:
If your appeals are exhausted or you want support during the process, several options exist depending on your situation:
Understanding where you are in the process — and what that stage requires — is what separates an appeal that moves forward from one that stalls.
